Kite Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Kite Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $287.07 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2017-08-08
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $287.07M.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $179.33M.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $83.22M.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $101.41M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2017-06-30 | $287.07M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $179.33M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $83.22M 10-K · filed 2017-02-28 |
| 2016-09-30 | $101.41M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $82.59M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $67.07M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $94.82M 10-K · filed 2016-02-29 |
| 2015-09-30 | $82.24M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $93.09M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $71.03M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $64.70M 10-K · filed 2015-03-26 |
| 2014-09-30 | $27.24B 10-Q · filed 2014-11-14 |
| 2014-06-30 | $22.99M 10-Q · filed 2014-08-14 |